Remove tag oligonucleotide
article thumbnail

Oligonucleotide synthesis market to reach $16.7 billion by 2027

European Pharmaceutical Review

According to a new market report by ResearchAndMarkets, the global oligonucleotide synthesis market is projected to reach $16.7 billion by 2027 during the forecast period, due to the rise in ongoing clinical trials for oligonucleotide-based therapies in key therapeutic sectors such as oncology. Synthesised oligonucleotides.

article thumbnail

Putting complex medicines under the microscope

European Pharmaceutical Review

Complex medicines include a variety of advanced drug chemistries and therapeutic targeting vehicles, comprising complex APIs eg, antibody-drug conjugates , oligonucleotide conjugates, complex formulations eg nanomedicines, or complex routes of delivery. Figure 1 : The proposed Medicines Discovery Catapult classification of complex medicines.